April 21, 2006

FOR RELEASE:  Immediately

CTS Introduces New “Composite” Piezoelectric Materials for the Medical Ultrasound Industry

Elkhart, IN…CTS Corporation (NYSE: CTS), a global leader in the design and manufacturing of ceramic piezoelectric materials, wafers and components, today announced the release of two new composite piezoelectric materials for use in the medical ultrasound industry.

Piezoelectric composite materials consist of a piezoelectric ceramic in a thermosetting epoxy matrix. CTS’ new piezoelectric composite materials offer clear advantages over traditional monolithic piezoelectric ceramics, which are used by the medical ultrasound industry to improve imaging capabilities. These advantages include: lower material densities, enhanced electromechanical coupling factors, lower crosstalk, increased acoustic sensitivity, broader bandwidth and improved conformity to the backing material’s shape.

CTS’ piezoelectric composite materials are available in any material formulation and can be prepared as a bare element or with electrodes made of sputtered nickel, tin, nichrome or gold. They are available in various thicknesses down to 0.005 inches. CTS also produces a wide range of surface finishes compatible with next-level assembly. 

For more information on CTS’ new composite piezoelectric materials, please contact Scott Hulick at (505) 348-4213.
 

About Electronic Components
CTS Electronic Components designs and manufactures passive components used in telecommunications equipment, mobile handsets, electronics hardware and military/aerospace applications for OEMs and Contract Manufacturers worldwide. CTS Electronic Components has manufacturing locations in Albuquerque, New Mexico; Berne, Indiana; Singapore; Dongguan and Tianjin, China; and Kaohsiung, Taiwan.
 

About CTS
CTS is a leading designer and manufacturer of electronic components and sensors and a provider of electronics manufacturing services (EMS) to OEMs in the automotive, computer, communications, medical and industrial markets.  CTS manufactures products in North America, Europe and Asia. CTS' stock is traded on the NYSE under the ticker symbol "CTS." 
 

Safe Harbor Statement
This press release contains certain statements that are, or may be deemed to be, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These forward-looking statements include, but are not limited to, any financial or other guidance, and all statements that are not based on historical fact, but rather reflect our current expectations concerning future results and events.  We make certain assumptions when making forward-looking statements, any of which could prove inaccurate, including, but not limited to, statements about our future operating results and business plans.  The ultimate correctness of these forward-looking statements is dependent upon a number of known and unknown risks and events, and is subject to various uncertainties and other factors that may cause our actual results, performance, or achievements to be different from any future results, performance, or achievements expressed or implied by these statements.

For more detailed information on the risks and uncertainties associated with CTS' business activities, see our reports filed with the SEC.  CTS undertakes no obligation to publicly update its forward-looking statements, whether as a result of market or industry changes, new information or future events.